Cargando…

Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M

The zoonotic disease brucellosis, a chronic condition in humans affecting renal and cardiac systems and causing osteoarthritis, is caused by Brucella, a genus of Gram-negative, facultative, intracellular pathogens. The mode of transmission and the virulence of the pathogens are still enigmatic. Tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradeepkiran, Jangampalli Adi, Kumar, Konidala Kranthi, Kumar, Yellapu Nanda, Bhaskar, Matcha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386771/
https://www.ncbi.nlm.nih.gov/pubmed/25848225
http://dx.doi.org/10.2147/DDDT.S77020
_version_ 1782365205194342400
author Pradeepkiran, Jangampalli Adi
Kumar, Konidala Kranthi
Kumar, Yellapu Nanda
Bhaskar, Matcha
author_facet Pradeepkiran, Jangampalli Adi
Kumar, Konidala Kranthi
Kumar, Yellapu Nanda
Bhaskar, Matcha
author_sort Pradeepkiran, Jangampalli Adi
collection PubMed
description The zoonotic disease brucellosis, a chronic condition in humans affecting renal and cardiac systems and causing osteoarthritis, is caused by Brucella, a genus of Gram-negative, facultative, intracellular pathogens. The mode of transmission and the virulence of the pathogens are still enigmatic. Transcription regulatory elements, such as rho proteins, play an important role in the termination of transcription and/or the selection of genes in Brucella. Adverse effects of the transcription inhibitors play a key role in the non-successive transcription challenges faced by the pathogens. In the investigation presented here, we computationally predicted the transcription termination factor rho (TtFRho) inhibitors against Brucella melitensis 16M via a structure-based method. In view the unknown nature of its crystal structure, we constructed a robust three-dimensional homology model of TtFRho’s structure by comparative modeling with the crystal structure of the Escherichia coli TtFRho (Protein Data Bank ID: 1PVO) as a template in MODELLER (v 9.10). The modeled structure was optimized by applying a molecular dynamics simulation for 2 ns with the CHARMM (Chemistry at HARvard Macromolecular Mechanics) 27 force field in NAMD (NAnoscale Molecular Dynamics program; v 2.9) and then evaluated by calculating the stereochemical quality of the protein. The flexible docking for the interaction phenomenon of the template consists of ligand-related inhibitor molecules from the ZINC (ZINC Is Not Commercial) database using a structure-based virtual screening strategy against minimized TtFRho. Docking simulations revealed two inhibitors compounds – ZINC24934545 and ZINC72319544 – that showed high binding affinity among 2,829 drug analogs that bind with key active-site residues; these residues are considered for protein-ligand binding and unbinding pathways via steered molecular dynamics simulations. Arg215 in the model plays an important role in the stability of the protein-ligand complex via a hydrogen bonding interaction by aromatic-π contacts, and the ADMET (absorption, distribution, metabolism, and excretion) analysis of best leads indicate nontoxic in nature with good potential for drug development.
format Online
Article
Text
id pubmed-4386771
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43867712015-04-06 Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M Pradeepkiran, Jangampalli Adi Kumar, Konidala Kranthi Kumar, Yellapu Nanda Bhaskar, Matcha Drug Des Devel Ther Original Research The zoonotic disease brucellosis, a chronic condition in humans affecting renal and cardiac systems and causing osteoarthritis, is caused by Brucella, a genus of Gram-negative, facultative, intracellular pathogens. The mode of transmission and the virulence of the pathogens are still enigmatic. Transcription regulatory elements, such as rho proteins, play an important role in the termination of transcription and/or the selection of genes in Brucella. Adverse effects of the transcription inhibitors play a key role in the non-successive transcription challenges faced by the pathogens. In the investigation presented here, we computationally predicted the transcription termination factor rho (TtFRho) inhibitors against Brucella melitensis 16M via a structure-based method. In view the unknown nature of its crystal structure, we constructed a robust three-dimensional homology model of TtFRho’s structure by comparative modeling with the crystal structure of the Escherichia coli TtFRho (Protein Data Bank ID: 1PVO) as a template in MODELLER (v 9.10). The modeled structure was optimized by applying a molecular dynamics simulation for 2 ns with the CHARMM (Chemistry at HARvard Macromolecular Mechanics) 27 force field in NAMD (NAnoscale Molecular Dynamics program; v 2.9) and then evaluated by calculating the stereochemical quality of the protein. The flexible docking for the interaction phenomenon of the template consists of ligand-related inhibitor molecules from the ZINC (ZINC Is Not Commercial) database using a structure-based virtual screening strategy against minimized TtFRho. Docking simulations revealed two inhibitors compounds – ZINC24934545 and ZINC72319544 – that showed high binding affinity among 2,829 drug analogs that bind with key active-site residues; these residues are considered for protein-ligand binding and unbinding pathways via steered molecular dynamics simulations. Arg215 in the model plays an important role in the stability of the protein-ligand complex via a hydrogen bonding interaction by aromatic-π contacts, and the ADMET (absorption, distribution, metabolism, and excretion) analysis of best leads indicate nontoxic in nature with good potential for drug development. Dove Medical Press 2015-03-31 /pmc/articles/PMC4386771/ /pubmed/25848225 http://dx.doi.org/10.2147/DDDT.S77020 Text en © 2015 Pradeepkiran et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Pradeepkiran, Jangampalli Adi
Kumar, Konidala Kranthi
Kumar, Yellapu Nanda
Bhaskar, Matcha
Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M
title Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M
title_full Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M
title_fullStr Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M
title_full_unstemmed Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M
title_short Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M
title_sort modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in brucella melitensis 16m
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386771/
https://www.ncbi.nlm.nih.gov/pubmed/25848225
http://dx.doi.org/10.2147/DDDT.S77020
work_keys_str_mv AT pradeepkiranjangampalliadi modelingmoleculardynamicsanddockingassessmentoftranscriptionfactorrhoapotentialdrugtargetinbrucellamelitensis16m
AT kumarkonidalakranthi modelingmoleculardynamicsanddockingassessmentoftranscriptionfactorrhoapotentialdrugtargetinbrucellamelitensis16m
AT kumaryellapunanda modelingmoleculardynamicsanddockingassessmentoftranscriptionfactorrhoapotentialdrugtargetinbrucellamelitensis16m
AT bhaskarmatcha modelingmoleculardynamicsanddockingassessmentoftranscriptionfactorrhoapotentialdrugtargetinbrucellamelitensis16m